Form 4 for DTIL PRECISION BIOSCIENCES INC
Accepted 2022-04-28 00:00:00 ET · period of report 2022-04-26 · accession 0001209191-22-026041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-28 | 2022-04-26 | DTIL | List Alan | Chief Medical Off | M - OptEx | — | +26.0K | 26.0K | New | — |
| D | 2022-04-28 | 2022-04-27 | DTIL | List Alan | Chief Medical Off | S - Sale+OE | $2.10 | -7,775 | 18.3K | -30% | -$16.3K |
| D | 2022-04-28 | 2022-04-26 | DTIL | List Alan | Chief Medical Off | M - OptEx | $0.00 | -26.0K | 52.1K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-26 | M | A | 26,035 | — | 26,035 | D | — | — | (F1) Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on April 26, 2022. (F2) Each RSU represents a contingent right to receive one share of the Company's Common Stock. |
| 2 | Common | Common Stock | 2022-04-27 | S | D | 7,775 | $2.10 | 18,260 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-04-26 | M | D | 26,035 | $0.00 | 52,055 | D | — · — to — | 26,035 Common Stock | (F2) Each RSU represents a contingent right to receive one share of the Company's Common Stock. (F4) On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on April 26, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates. |